News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
866,878 Results
Type
Article (87750)
Company Profile (824)
Press Release (778287)
Multimedia
Podcasts (186)
Webinars (28)
Section
Business (233167)
Career Advice (4143)
Deals (39830)
Drug Delivery (144)
Drug Development (91355)
Employer Resources (203)
FDA (18355)
Job Trends (17414)
News (397700)
Policy (39947)
Tag
Academia (3006)
Academic (2)
Accelerated approval (25)
Adcomms (35)
Allergies (134)
Alliances (56980)
ALS (170)
Alzheimer's disease (1759)
Antibody-drug conjugate (ADC) (302)
Approvals (18458)
Artificial intelligence (578)
Autoimmune disease (132)
Automation (33)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (189)
Biotechnology (488)
Bladder cancer (150)
Brain cancer (61)
Breast cancer (613)
Cancer (4666)
Cardiovascular disease (408)
Career advice (3565)
Career pathing (40)
CAR-T (289)
CDC (59)
Celiac Disease (1)
Cell therapy (783)
Cervical cancer (36)
Clinical research (76527)
Collaboration (1587)
Company closure (5)
Compensation (1064)
Complete response letters (65)
COVID-19 (2978)
CRISPR (93)
C-suite (736)
Cystic fibrosis (147)
Data (5810)
Decentralized trials (2)
Denatured (68)
Depression (132)
Diabetes (492)
Diagnostics (7165)
Digital health (42)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (270)
Drug pricing (206)
Drug shortages (36)
Duchenne muscular dystrophy (224)
Earnings (99886)
Editorial (60)
Employer branding (25)
Employer resources (173)
Events (134493)
Executive appointments (1009)
FDA (21199)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (21)
Funding (1430)
Gene editing (201)
Generative AI (60)
Gene therapy (620)
GLP-1 (1082)
Government (5419)
Grass and pollen (8)
Guidances (379)
Healthcare (20941)
HIV (54)
Huntington's disease (45)
IgA nephropathy (80)
Immunology and inflammation (276)
Immuno-oncology (40)
Indications (76)
Infectious disease (3248)
Inflammatory bowel disease (197)
Inflation Reduction Act (16)
Influenza (111)
Intellectual property (217)
Interviews (816)
IPO (17942)
IRA (59)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (88)
Layoffs (652)
Leadership (38)
Legal (10153)
Liver cancer (94)
Longevity (14)
Lung cancer (646)
Lymphoma (358)
Machine learning (40)
Management (66)
Manufacturing (742)
MASH (165)
Medical device (14967)
Medtech (15006)
Mergers & acquisitions (22872)
Metabolic disorders (1287)
Multiple sclerosis (152)
NASH (23)
Neurodegenerative disease (322)
Neuropsychiatric disorders (86)
Neuroscience (2955)
NextGen: Class of 2025 (7703)
Non-profit (5102)
Now hiring (61)
Obesity (618)
Opinion (326)
Ovarian cancer (153)
Pain (188)
Pancreatic cancer (198)
Parkinson's disease (272)
Partnered (34)
Patents (469)
Patient recruitment (402)
Peanut (58)
People (66623)
Pharmaceutical (145)
Pharmacy benefit managers (30)
Phase I (23625)
Phase II (33218)
Phase III (25038)
Pipeline (3846)
Policy (319)
Postmarket research (3554)
Preclinical (10663)
Press Release (72)
Prostate cancer (227)
Psychedelics (52)
Radiopharmaceuticals (286)
Rare diseases (803)
Real estate (7436)
Recruiting (80)
Regulatory (28545)
Reports (65)
Research institute (2715)
Resumes & cover letters (651)
Rett syndrome (24)
RNA editing (16)
RSV (82)
Schizophrenia (148)
Series A (234)
Series B (177)
Service/supplier (30)
Sickle cell disease (100)
Special edition (26)
Spinal muscular atrophy (174)
Sponsored (47)
Startups (4325)
State (2)
Stomach cancer (19)
Supply chain (106)
Tariffs (97)
The Weekly (116)
Vaccines (1104)
Venture capital (77)
Weight loss (433)
Women's health (78)
Worklife (21)
Date
Today (91)
Last 7 days (624)
Last 30 days (2522)
Last 365 days (33324)
2025 (32414)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (86)
Alaska (7)
Arizona (325)
Arkansas (14)
Asia (51308)
Australia (9016)
California (10785)
Canada (3168)
China (1049)
Colorado (453)
Connecticut (479)
Delaware (322)
Europe (117954)
Florida (1579)
Georgia (348)
Hawaii (3)
Idaho (68)
Illinois (889)
India (62)
Indiana (519)
Iowa (22)
Japan (375)
Kansas (130)
Kentucky (41)
Louisiana (28)
Maine (81)
Maryland (1395)
Massachusetts (7992)
Michigan (341)
Minnesota (625)
Mississippi (6)
Missouri (132)
Montana (34)
Nebraska (27)
Nevada (117)
New Hampshire (81)
New Jersey (2943)
New Mexico (32)
New York (2886)
North Carolina (1531)
North Dakota (10)
Northern California (5081)
Ohio (330)
Oklahoma (22)
Oregon (52)
Pennsylvania (2188)
Puerto Rico (20)
Rhode Island (48)
South America (1656)
South Carolina (60)
South Dakota (1)
Southern California (4140)
Tennessee (167)
Texas (1696)
United States (39247)
Utah (323)
Vermont (1)
Virginia (270)
Washington D.C. (85)
Washington State (913)
West Virginia (4)
Wisconsin (112)
Wyoming (2)
There are 866,878 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Multiple sclerosis
Sanofi’s MS Drug Fails Phase III Trial, While FDA Again Delays Approval Application
Sanofi’s multiple sclerosis hopeful tolebrutinib faced dual setbacks on Monday, with a late-stage failure in one form of the disease and yet another regulatory setback in another.
December 15, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
Algia Pharma Gains FDA Support to Advance Novel Non-Opioid Pain Treatment Toward a Phase 2 Clinical Trial After IND-Enabling Studies With Indication Expanded to All Mild-to-Moderate Acute Pain
December 15, 2025
·
3 min read
Press Releases
Aviceda Therapeutics Announces Phase 2b SIGLEC Results for AVD-104 in Geographic Atrophy
December 15, 2025
·
7 min read
Press Releases
Immunome Announces Positive Topline Results from Phase 3 RINGSIDE Trial of Varegacestat in Patients with Desmoid Tumors
December 15, 2025
·
8 min read
Press Releases
U.S. Food and Drug Administration Approves LIB Therapeutics’ LEROCHOL™ (lerodalcibep-liga) for Adults with Elevated LDL Cholesterol
December 15, 2025
·
6 min read
Press Releases
Cencora Accelerates OneOncology Acquisition, Extending Solutions Offering for Community Oncology
December 15, 2025
·
11 min read
Press Releases
Companion Spine Announces FDA Premarket Approval (“PMA”) of the DIAM™ Spinal Stabilization System for the Treatment of Degenerative Disc Disease (“DDD”)
December 15, 2025
·
10 min read
Press Releases
Attivare Therapeutics Awarded $6.6 Million Grant to Advance Durable Malaria Vaccine
December 15, 2025
·
2 min read
Press Releases
Pharmanovia Announces Launch of Korjuny (Catumaxomab) in Germany, a First-in-class Treatment for Malignant Ascites
December 15, 2025
·
5 min read
Approvals
Milestone’s Long Regulatory Road Ends in Approval for Cardamyst
The FDA had previously turned back the heart rhythm nasal spray twice, once in late 2023 with a refusal to file letter and again in March this year, when it flagged manufacturing issues.
December 15, 2025
·
2 min read
·
Tristan Manalac
1 of 86,688
Next
